Theralase Technologies Inc. (CVE:TLT) (OTCMKTS:TLTFF) announced today that in preclinical animal testing, performed at Princess Margaret Cancer Centre, University Health Network ("UHN"), it has discovered that its lead Photo Dynamic Compound (PDC), intended for the destruction of cancer, has demonstrated an ability to render animals immune to repeated exposures of the same cancer.
Sunridge International (PINK:SNDZ), announced today that it will not be moving forward with the sale of its assets to Westhouse Medical of London, England due to Westhouse's failure to make certain payments as required by the asset purchase agreement entered into between the parties.
Healthcare specialist Westhouse Medical Services Plc (FRA:5WM) is pleased to announce that following its announcement of its acquisition of 52% of the issued share capital of Quy Biosciences Limited (Quy) through private placement in November 2012
Healthcare specialist Westhouse Medical Services Plc (FRA:5WM) today announces the appointment of Mr Nigel Kershaw OBE as Non-Executive Director. Nigel is Group Chairman of The Big Issue having previously been its Chief Executive.
Healthcare specialist Westhouse Medical Services Plc (FRA:5WM) today announces the appointment of Ms Joanne Smith as Non-Executive Director. Joanne Smith has worked in Financial Services for over 20 years. Her expertise is in compliance related matters, across all sectors of the industry.
Healthcare specialist Westhouse Medical Services Plc (FRA:5WM) today announces the appointment of Mr Kevin Riches as Non-Executive Director. Kevin has over 25 years experience in start up and mature businesses, both large and small.
Westhouse is currently developing a number of medical devices, including BreastCheck - a new low-cost, non-invasive breast cancer screening product which can act as a precursor to mammogram scanning. BreastCheck is due for launch in 2013.
